: Cement maker ACC Tuesday reported a 38.19 per cent increase in its consolidated profit at Rs 346.02 crore for the first quarter ended March 2019, helped by increase in sales volume.
Drug maker Lupin on Tuesday said the US health regulator has cautioned that the firm's Pithampur facility may be subject to regulatory or administrative action and that it may withhold approval of any pending applications or supplements in which this facility is listed.
Embassy office Parks, which recently raised Rs 4,750 crore through India's first Real Estate Investment Trust (REIT), Tuesday said it will raise Rs 3,650 crore in two tranches through the issue of debentures.
Sasken Technologies: The company's board has recommended a final dividend of Rs 7.50 per equity share of Rs 10 each for the year ended March 31, 2019.
As per news
reports, Huawei Cloud and Infosys have entered into a strategic cooperation to help enterprise customers transition quickly to the digital cloud.
Sterlite Technologies: The company posted about 47 per cent rise in consolidated net profit to Rs 165.17 crore for the quarter ended March 2019. The company's board also approved fund-raising of up to Rs 1,000 crore.
Tata Global Beverages:
Tata Global Beverages (TGBL) on Tuesday reported 49.70 per cent fall in consolidated net profit at Rs 35.99 crore for the March quarter of 2018-19 financial year.
ICICI Securities: ICICI Securities on Tuesday reported 19.5 per cent decline in consolidated profit at Rs 121.5 crore for the March quarter of 2018-19 financial year.
Fertiliser and crop protection chemical company Coromandel International Limited has reported a 23 per cent increase in consolidated net profit at Rs 110.38 crore for the quarter ended March, 2019 as compared with Rs 89.61 crore in the corresponding quarter previous year.
ITC, Hotel Leela:
Barely a month after Brookfield closed a deal to buy four hotels and a property of Hotel Leelaventure, ITC, which has a 8.72 per cent stake in the hospitality firm, has filed a petition in the National Company Law Tribunal (NCLT), accusing the company of oppression and mismanagement.
Hyderabad-based Dr Reddy’s Laboratories (DRL), which is betting big on the Chinese drug market, recently got an approval for a $1.6-billion anti-blood clotting drug from the Chinese regulator after an 11-year wait.
P&G India: The GST profiteering investigation arm has found leading FMCG firm P&G India guilty of not passing on GST rate cut benefits to the tune of about Rs 250 crore by a commensurate reduction in prices.